Citius Pharmaceuticals Inc (CTXR)
0.7515
-0.04
(-4.87%)
USD |
NASDAQ |
Apr 19, 14:47
Citius Pharmaceuticals Max Drawdown (5Y): 98.88% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 98.88% |
February 29, 2024 | 98.88% |
January 31, 2024 | 98.88% |
December 31, 2023 | 98.88% |
November 30, 2023 | 98.88% |
October 31, 2023 | 98.88% |
September 30, 2023 | 98.88% |
August 31, 2023 | 98.88% |
July 31, 2023 | 98.88% |
June 30, 2023 | 98.88% |
May 31, 2023 | 98.88% |
April 30, 2023 | 98.88% |
March 31, 2023 | 98.88% |
February 28, 2023 | 98.88% |
January 31, 2023 | 98.88% |
December 31, 2022 | 98.88% |
November 30, 2022 | 98.88% |
October 31, 2022 | 98.88% |
September 30, 2022 | 98.88% |
August 31, 2022 | 98.88% |
July 31, 2022 | 98.88% |
June 30, 2022 | 98.88% |
May 31, 2022 | 98.88% |
April 30, 2022 | 98.88% |
March 31, 2022 | 98.88% |
Date | Value |
---|---|
February 28, 2022 | 98.88% |
January 31, 2022 | 98.88% |
December 31, 2021 | 98.88% |
November 30, 2021 | 98.88% |
October 31, 2021 | 98.88% |
September 30, 2021 | 98.88% |
August 31, 2021 | 98.88% |
July 31, 2021 | 98.88% |
June 30, 2021 | 98.88% |
May 31, 2021 | 98.88% |
April 30, 2021 | 98.88% |
March 31, 2021 | 98.88% |
February 28, 2021 | 98.88% |
January 31, 2021 | 98.88% |
December 31, 2020 | 98.88% |
November 30, 2020 | 98.88% |
October 31, 2020 | 98.88% |
September 30, 2020 | 98.88% |
August 31, 2020 | 98.88% |
July 31, 2020 | 98.88% |
June 30, 2020 | 98.88% |
May 31, 2020 | 98.88% |
April 30, 2020 | 98.88% |
March 31, 2020 | 98.88% |
February 29, 2020 | 98.88% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.71%
Minimum
Apr 2019
98.88%
Maximum
Dec 2019
98.77%
Average
98.88%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
QuidelOrtho Corp | 86.17% |
TransCode Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 99.90% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -29.64 |
Beta (5Y) | 1.446 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 93.42% |
Historical Sharpe Ratio (5Y) | -0.1153 |
Historical Sortino (5Y) | -0.2462 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.85% |